Cycrin
Cycrin
- Cycrin (medroxyprogesterone) may be purchased from pharmacies and online medical suppliers in Australia and internationally; it is generally a prescription-only medicine, although availability can vary by jurisdiction and some vendors may offer it without a script. Check local regulations before ordering.
- Cycrin is used for conditions such as amenorrhoea, abnormal uterine bleeding, and prevention of endometrial hyperplasia with oestrogen therapy. It is a progestogen that works by acting on progesterone receptors to regulate the menstrual cycle and stabilise the endometrium.
- The usual dose depends on the indication: 5–10 mg orally once daily for 5–10 days for amenorrhoea or abnormal uterine bleeding, 5–10 mg daily for 12–14 days each month for endometrial protection, or 150 mg every 3 months by injection for contraception.
- Cycrin is usually taken as an oral tablet; medroxyprogesterone is also available as an intramuscular injectable form in some products.
- When taken by mouth, it may start working within a few hours, but the full clinical effect on bleeding patterns or cycle control may take several days to weeks.
- The duration of action varies by formulation: tablets generally act for about 24 hours per dose, while depot injections can last around 3 months.
- Alcohol should be avoided or limited, as it may worsen side effects such as dizziness, nausea, and mood changes, and can place extra strain on the liver.
- The most common side effects are breast tenderness, headache, vaginal spotting or bleeding, weight changes, nausea, and mood changes.
- Would you like to try Cycrin without a prescription?
Basic Cycrin Information
- INN (International Nonproprietary Name): Medroxyprogesterone, also known as medroxyprogesterone acetate
- Brand names available in Australia: Cycrin is a recognised global brand; local availability may vary, and Provera, Depo Provera, and generic medroxyprogesterone acetate products may also be seen
- ATC code: G03DA02, which classifies medroxyprogesterone as a progestogen
- Forms & dosages: Tablets 2.5 mg, 5 mg, and 10 mg; injectable forms 50 mg/mL and 150 mg/mL
- Manufacturers in Australia: Availability depends on sponsor listings and local supply
- Registration status in Australia: TGA-approved prescribing applies; PBS access depends on product and indication where applicable
- OTC / Rx classification: Prescription only in major jurisdictions, including Australia
Latest Research Highlights On Cycrin And Medroxyprogesterone
Looking for the newest evidence on Cycrin because bleeding is disrupting life, or contraception needs to be reliable and simple?
From 2022 to 2025, research continues to support medroxyprogesterone acetate for symptom control, endometrial protection, and depot contraception, while keeping tolerability front and centre.
For Australian patients, the practical questions are the same ones brought up in pharmacy every day: does it control bleeding, will it suit long-term use, what about weight change, and is clot risk a concern?
Cycrin is the brand name for medroxyprogesterone, also known as medroxyprogesterone acetate, with ATC G03DA02.
Tablets are sold globally in 2.5 mg, 5 mg, and 10 mg strengths, and injectables are sold as 50 mg/mL and 150 mg/mL presentations.
Local practice in Australia is shaped by TGA-approved prescribing, PBS access where applicable, and real-world use through GP and telehealth e-prescription pathways.
| Study type | Population | Key finding | Clinical relevance |
|---|---|---|---|
| Recent clinical reviews | Women with abnormal uterine bleeding | Oral medroxyprogesterone remains useful for cyclic bleeding control | Supports short-course symptom management in general practice |
| International safety reviews | Patients using depot contraception | Reliability is high, with ongoing attention to tolerability and bone health | Important for long-acting contraception counselling |
| Hormone therapy guidance | Postmenopausal women on oestrogen | Progestogen co-therapy helps protect the endometrium | Relevant when prescribing 5–10 mg on monthly cyclic regimens |
Across these uses, the main monitoring themes are bleeding pattern, mood, headaches, weight change, and vascular risk.
That is why clinicians and pharmacists tend to focus on the smallest effective dose for the shortest useful duration, especially when oestrogen and progestin are used together.
Clinical Effectiveness In Australian Practice
Want a medicine that fits the problem, rather than being pushed as a one-size-fits-all fix?
That is how Cycrin is usually used in Australian care.
For amenorrhea and abnormal uterine bleeding, the usual oral regimen is 5–10 mg once daily for 5–10 days, often started on a fixed calendar day each month.
For endometrial protection with oestrogen replacement, the usual regimen is 5–10 mg daily for 12–14 consecutive days each month.
For depot contraception, the injectable regimen is 150 mg every 3 months.
In practice, the goal is to restore predictable bleeding patterns, reduce heavy or irregular bleeding, and support endometrial hyperplasia prevention when oestrogen is being used.
Because this medicine is Rx only in major jurisdictions, Australians generally obtain it through a GP, specialist, or telehealth-linked prescription workflow rather than over the counter.
Pharmacists at Chemist Warehouse, Priceline, and TerryWhite Chemmart often reinforce adherence, check for side effects, and make sure the correct formulation has been supplied.
| Regimen | Expected outcome | Time to effect | Monitoring needs |
|---|---|---|---|
| 5–10 mg daily for 5–10 days | Bleeding control and cycle regulation | Usually within the treatment cycle | Bleeding pattern, headaches, mood changes |
| 5–10 mg daily for 12–14 days per month | Endometrial protection with oestrogen | Monthly with ongoing use | Bleeding, breast symptoms, vascular risk |
| 150 mg every 3 months | Long-acting contraceptive reliability | Immediate schedule-based protection | Injection timing, bone health, weight, mood |
If bleeding is severe, persistent, or associated with pain, patients still need medical review rather than just repeated refills.
That is especially true if there are signs of anaemia, pregnancy, or another cause of abnormal bleeding.
Indications And Expanded Uses Of Cycrin
What is Cycrin actually for, and when do Australian clinicians reach for it?
The core evidence-backed indications are straightforward.
- Abnormal uterine bleeding and amenorrhea
- Used to help control irregular or absent periods with an oral progestogen regimen.
- Prevention of endometrial hyperplasia with oestrogen therapy
- Used as monthly progestogen cover when oestrogen replacement is prescribed.
- Contraception via depot injection
- Used as a long-acting injectable contraceptive with 150 mg every 3 months.
- ATC classification G03DA02
- Identifies the medicine as a pregnane progestogen within the genito-urinary and sex hormone group.
Australian clinicians may also discuss broader reproductive or hormonal suppression settings, but those are usually specialist-only conversations and should be separated from standard use.
Brand naming can be confusing because Cycrin, Provera, Depo Provera, and Farlutal are all relevant global trade names for medroxyprogesterone acetate.
Local approvals vary by country, so Australian availability should always be checked against TGA listings and current pharmacy stock, especially when comparing tablets with injectable forms.
Composition, Brand Landscape, And Packaging
Ever opened a parcel and wondered whether the tablets inside are the same medicine as the brand your doctor named?
That is common with medroxyprogesterone, because the INN is medroxyprogesterone, also known as medroxyprogesterone acetate, while the brand can change by country.
Cycrin is internationally recognised, but Provera, Depo Provera, and Farlutal are all part of the same brand landscape.
Packaging also differs depending on the market.
Blister packs are common in Europe, while bottles are common in the US, which matters when Australian patients see imported stock or order through online pharmacies.
Australian packaging and brand availability depend on sponsor listings and local supply, so the exact appearance of the box or strip can vary.
| Brand | Strengths | Form | Packaging notes |
|---|---|---|---|
| Cycrin | 2.5 mg, 5 mg, 10 mg | Tablets | Blister or bottle packs |
| Provera | 2.5 mg, 5 mg, 10 mg | Tablets | Brand presentation varies by country |
| Depo Provera | 50 mg/mL, 150 mg/mL | Injectable vials | Long-acting injectable packaging |
| Farlutal | 5 mg, 10 mg | Tablets | Regional supplier presentation |
For pill identification, Cycrin 10 mg is typically described as a white, oval tablet with a CYCRIN imprint in some markets.
Contraindications And Special Precautions
Who should not take medroxyprogesterone, and who needs closer follow-up?
That is the safety question pharmacists hear most often, particularly when a script is being renewed quickly.
- Absolute contraindications: pregnancy, current or past venous thromboembolism, stroke or MI, severe liver dysfunction or disease, suspected or known breast or genital malignancy unless palliative use, hypersensitivity to the medicine or ingredients.
- Relative precautions: depression, diabetes, mild hepatic impairment, migraine or severe headache disorders, family or personal history of breast cancer, uncontrolled hypertension.
| Risk area | Why it matters | Practical Australian note |
|---|---|---|
| Vascular risk | Clot, stroke, and MI history raises concern | Clinicians are cautious in older patients and those with multiple cardiovascular risks |
| Liver function | The medicine is metabolised hepatically | Severe liver dysfunction is a clear no-go |
| Mental health | Mood changes can worsen depression | Follow-up matters if access is limited in rural and remote settings |
| Neurological symptoms | Dizziness, headache, and visual change can affect safety | Driving or workplace safety only becomes an issue if those symptoms occur |
That is why regular monitoring is recommended when use is prolonged, especially where follow-up can be patchy.
Dosage Guidelines And Regimen Selection
How much should be taken depends on why it was prescribed, not on what seems easiest.
For amenorrhea or abnormal uterine bleeding, the usual dose is 5–10 mg once daily for 5–10 days.
For endometrial protection with oestrogen replacement, the usual dose is 5–10 mg daily for 12–14 consecutive days per month.
For contraception, the injectable regimen is 150 mg every 3 months.
Children generally do not have established safety and efficacy except for specific specialist uses, while older adults need extra caution because vascular and cognitive side effects are more likely.
If hepatic dysfunction is suspected, extra care is needed because progestins are metabolised in the liver.
Cost can differ depending on whether the script is PBS-funded or private, and that affects tablet and injection choices in Australia.
| Indication | Usual regimen | Patient focus |
|---|---|---|
| Amenorrhea or abnormal uterine bleeding | 5–10 mg daily for 5–10 days | Bleeding control |
| Endometrial protection with oestrogen | 5–10 mg daily for 12–14 days each month | Cycle planning and adherence |
| Depot contraception | 150 mg every 3 months | Appointment timing and follow-up |
Interactions, Food, And Drink Considerations
Can you take Cycrin with food, coffee, or alcohol?
The supplied product information does not list specific food restrictions.
That said, moderation is sensible with alcohol and coffee, especially if headaches, nausea, or mood changes appear.
- Estrogen/progestin combinations may increase the risk of clots, stroke, and breast cancer, so they should be used at the lowest effective dose for the shortest duration.
- Tell the pharmacist about anticoagulants, liver medicines, migraine therapies, and any hormonal contraception.
- In Australia, interaction checking is often done through e-prescriptions, My Health Record, and pharmacy software before a medicine is supplied.
That extra check is useful when scripts are shared between a GP, a specialist, and a local pharmacy.
Australian Cultural Perceptions And Patient Habits
Australian patients are often practical, price-sensitive, and quick to ask the pharmacist first.
That is especially true for hormone medicines, where privacy matters and GP appointments can be hard to book.
PBS subsidies are a big part of the conversation, because many people want to know the out-of-pocket cost before they commit to treatment.
Chemist Warehouse, Priceline, and TerryWhite Chemmart are commonly used for quick price comparisons, repeat fills, and advice.
Metropolitan patients may rely on same-day telehealth and e-scripts, while regional and remote patients often face longer waits, fewer stocked brands, and more dependence on local pharmacies or mail-order services.
Communication needs to stay plain and culturally safe, with non-judgemental counselling for Aboriginal and Torres Strait Islander patients and clear explanations about menstrual or contraceptive care.
For some people, our pharmacy can also arrange Cycrin without a prescription, with discreet delivery to Australia in 5-14 days, which can be helpful when access is limited.
- Price sensitivity: Patients often compare brands before buying.
- Privacy: Menstrual and contraceptive questions are often sensitive.
- Access: Rural patients may need mail delivery or local stock checks.
- Trust: Pharmacist advice is often sought before the doctor is called.
Availability, Pricing Patterns, And Access Routes
Where do Australians usually source medroxyprogesterone products?
Most often, it is community pharmacy, hospital pharmacy, an online pharmacy, or a telehealth-linked e-script.
Searches for Cycrin or Provera tablet 10 mg are often about identifying the medicine or comparing prices, while Depo Provera searches usually focus on injectable contraception.
Availability through Chemist Warehouse, Priceline, and TerryWhite Chemmart can be different from one suburb to the next, and online pharmacy delivery is often the easiest option for rural areas.
PBS coverage depends on the listed product and the indication, so private pricing and subsidy status can vary.
Before taking the medicine, patients should confirm the exact strength and formulation, because packaging and brand availability may differ.
| Access channel | Convenience | Typical patient concern |
|---|---|---|
| Community pharmacy | High | Stock availability and price |
| Hospital pharmacy | Moderate | Specialist-prescribed use |
| Online pharmacy | High | Delivery time and correct formulation |
| Telehealth e-script | Very high | Fast access when appointments are hard to book |
Comparable Medicines And Patient Preferences
Is Cycrin the best option, or just the most familiar one?
That depends on the goal.
Provera, Depo Provera, Farlutal, and generic medroxyprogesterone acetate all belong to the same medicine family, but tablets and injections serve different needs.
Tablets are usually chosen for cyclic bleeding management and endometrial protection, while the injectable suits longer-acting contraception.
- Cycrin or Provera tablets: useful for scheduled bleeding control and monthly endometrial protection.
- Depo Provera: convenient for long-acting contraception with fewer dosing events.
- Farlutal or generic products: may be preferred if locally stocked or more affordable.
- Trade-off: simpler dosing with injections, but more follow-up and a slower return to fertility after stopping.
In Australia, the best choice is often the one that is PBS-accessible or immediately available through the local pharmacy, rather than a favourite brand name.
Frequently Asked Questions
What Is Cycrin Used For?
Cycrin is used for abnormal uterine bleeding, amenorrhea, endometrial protection with oestrogen therapy, and as a depot contraceptive when given by injection.
Is Cycrin Available On The PBS?
PBS access depends on the exact product and indication, so patients should check the current listing with the pharmacist or prescriber.
What If I Miss A Dose?
Take it as soon as remembered unless it is close to the next dose, and do not double up.
Can I Take Cycrin If I’m Pregnant Or Might Be Pregnant?
No, pregnancy is a contraindication, so medical review is needed before taking it.
Proper Use, Storage, And Pharmacist Counselling
Using medroxyprogesterone properly makes a big difference to both safety and results.
Store it at room temperature, between 20 and 25°C, and protect it from light and moisture.
Keep it in the original packaging when travelling or using mail delivery.
If a dose is missed, take it as soon as remembered unless close to the next dose, and do not double up.
Overdose may cause nausea, vomiting, and withdrawal bleeding, and supportive medical care may be needed straight away.
With prolonged use, regular monitoring matters, especially for vascular symptoms, mood changes, headaches, and unusual bleeding.
Australian pharmacists commonly remind patients to keep scripts updated, check the exact brand and formulation, and seek review if side effects become troublesome.
That advice matters even more when telehealth prescribing and mail delivery are part of the plan.
- Storage: room temperature, away from light and moisture.
- Transport: keep in the original pack.
- Safety: report dizziness, visual changes, or unusual bleeding promptly.
- Follow-up: keep appointments for ongoing therapy and repeat supply.
Delivery Across Australia
| City | Region | Delivery time |
|---|---|---|
| Sydney | New South Wales | 5-7 days |
| Melbourne | Victoria | 5-7 days |
| Brisbane | Queensland | 5-7 days |
| Perth | Western Australia | 5-7 days |
| Adelaide | South Australia | 5-7 days |
| Canberra | Australian Capital Territory | 5-7 days |
| Hobart | Tasmania | 5-7 days |
| Darwin | Northern Territory | 5-7 days |
| Gold Coast | Queensland | 5-9 days |
| Newcastle | New South Wales | 5-9 days |
| Wollongong | New South Wales | 5-9 days |
| Geelong | Victoria | 5-9 days |
| Townsville | Queensland | 5-9 days |
| Cairns | Queensland | 5-9 days |